SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 9, 2001, Pages 2449-2455

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy

(9) Chinot, O L a Honore, S a Dufour, H a Barrie, M a Figarella Branger, D a Muracciole, X a Braguer, D a Martin, P M a Grisoli, F a

a TIMONE HOSPITAL (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL TOXICITY; GLIOBLASTOMA; HUMAN; OLIGODENDROGLIOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 0035340512 PISSN: 0732183X EISSN: None Source Type: Journal
DOI: 10.1200/JCO.2001.19.9.2449 Document Type: Article

Times cited : (174)

References (36)

1
- 0033008968
- Global cancer statistics
- (1999) CA Cancer J Clin , vol.49 , pp. 33-64
- Parkin, D.M.¹ Pisani, P.² Ferlay, J.³

2
- 0033006836
- Cancer statistics 1999 (erratum appears in CA Cancer J Clin 49:1, 1999)
- (1999) CA Cancer J Clin , vol.49 , pp. 8-31
- Landis, S.H.¹ Murray, T.² Bolden, S.³

3
- 0027523539
- The treatment of anaplastic oligodendrogliomas and mixed gliomas
- (1993) Neurosurgery , vol.32 , pp. 365-370
- Kyritsis, A.P.¹ Yung, W.K.² Bruner, J.³

4
- 0003043603
- Neoplasms of the central nervous system
- De Vita VT Jr, Hellman S, Rosenberg SA (eds): Philadelphia, PA, Lippincott-Raven
- (1997) Cancer: Principles and Practice of Oncology , pp. 2022-2082
- Levin, V.A.¹ Leibel, S.A.² Gutin, P.H.³

5
- 0030964081
- Radiation and chemotherapy improve outcome in oligodendroglioma
- (1997) Int J Radiat Oncol Biol Phys , vol.37 , pp. 399-403
- Allison, R.R.¹ Schulsinger, A.² Vongtama, V.³

6
- 0030979029
- Oligodendrogliomas: Part I. Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases
- (1997) J Neurooncol , vol.34 , pp. 37-59
- Daumas-Duport, C.¹ Varlet, P.² Tucker, M.L.³

7
- 0031010665
- Oligodendrogliomas: Part II. A new grading system based on morphological and imaging criteria
- (1997) J Neurooncol , vol.34 , pp. 61-78
- Daumas-Duport, C.¹ Tucker, M.L.² Kolles, H.³

8
- 0026787026
- Aggressive oligodendroglioma: A chemosensitive tumor
- (1992) Neurosurgery , vol.31 , pp. 78-82
- Cairncross, J.G.¹ MacDonald, D.R.² Ramsay, D.A.³

9
- 0023930146
- Successful chemotherapy for recurrent malignant oligodendroglioma
- (1988) Ann Neurol , vol.23 , pp. 360-364
- Cairncross, J.G.¹ MacDonald, D.R.²

10
- 0032494479
- Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
- (1998) J Natl Cancer Inst , vol.90 , pp. 1473-1479
- Cairncross, J.G.¹ Ueki, K.² Zlatescu, M.C.³

11
- 0026597158
- The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy
- (1992) J Neurosurg , vol.76 , pp. 741-745
- Glass, J.¹ Hochberg, F.H.² Gruber, M.L.³

12
- 0027276058
- Good performance status of long-term disease-free survivors of intracranial gliomas
- (1993) Int J Radiat Oncol Biol Phys , vol.26 , pp. 129-133
- Kleinberg, L.¹ Wallner, K.² Malkin, M.G.³

13
- 0029888804
- Low-grade oligodendroglioma responds to chemotherapy
- (1996) Neurology , vol.46 , pp. 203-207
- Mason, W.P.¹ Krol, G.S.² DeAngelis, L.M.³

14
- 0033942479
- Chemotherapy of oligodendroglial tumours: Current developments
- (2000) Forum (Genova) , vol.10 , pp. 108-118
- Van den Bent, M.J.¹

15
- 0029789493
- Salvage chemotherapy for oligodendroglioma
- (1996) J Neurosurg , vol.85 , pp. 597-601
- Peterson, K.¹ Paleologos, N.² Forsyth, P.³

16
- 0030698803
- Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas
- (1997) J Clin Oncol , vol.15 , pp. 3427-3432
- Chamberlain, M.C.¹ Kormanik, P.A.²

17
- 0026513077
- Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
- (1992) Br J Cancer , vol.65 , pp. 287-291
- Newlands, E.S.¹ Blackledge, G.R.² Slack, J.A.³

18
- 0027172819
- Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
- (1993) Eur J Cancer , vol.29 A , pp. 940-942
- O'Reilly, S.M.¹ Newlands, E.S.² Glaser, M.G.³

19
- 0030449301
- The Charing Cross Hospital experience with temozolomide in patients with gliomas
- (1996) Eur J Cancer , vol.32 A , pp. 2236-2241
- Newlands, E.S.¹ O'Reilly, S.M.² Glaser, M.G.³

20
- 0031426782
- Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer
- (1997) Clin Cancer Res , vol.3 , pp. 2393-2398
- Reid, J.M.¹ Stevens, D.C.² Rubin, J.³

21
- 0032728210
- Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
- (1999) Br J Cancer , vol.81 , pp. 1022-1030
- Brada, M.¹ Judson, I.² Beale, P.³

22
- 0030791133
- Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer
- (1997) Clin Cancer Res , vol.3 , pp. 1093-1100
- Dhodapkar, M.¹ Rubin, J.² Reid, J.M.³

23
- 0032855728
- Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse: Temodal Brain Tumor Group
- (1999) J Clin Oncol , vol.17 , pp. 2762-2771
- Yung, W.K.¹ Prados, M.D.² Yaya-Tur, R.³

24
- 0033897173
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
- (2000) Br J Cancer , vol.83 , pp. 588-593
- Yung, W.K.¹ Albright, R.E.² Olson, J.³

25
- 0018067833
- Evaluation of x-ray CT (EMI scan) and isotope brain studies, including radioisotope axial tomography
- (1978) Neuroradiology , vol.16 , pp. 575
- MacDonald, A.F.¹ Carrill, J.M.² Dendy, P.P.³

26
- 0031756784
- PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas
- (1998) Neurosurgery , vol.43 , pp. 1066-1073
- Soffietti, R.¹ Ruda, R.² Bradac, G.B.³

27
- 0031713125
- Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy: Dutch Neuro-oncology Group
- (1998) Neurology , vol.51 , pp. 1140-1145
- Van den Bent, M.J.¹ Kros, J.M.² Heimans, J.J.³

28
- 0033595435
- Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma
- (1999) Neurology , vol.53 , pp. 1141-1143
- Paleologos, N.A.¹ Macdonald, D.R.² Vick, N.A.³

29
- 0028325824
- Mixed oligoastrocytomas: A survival and prognostic factor analysis
- (1994) Neurosurgery , vol.34 , pp. 577-582
- Shaw, E.G.¹ Scheithauer, B.W.² O'Fallon, J.R.³

30
- 0026509455
- Oligodendrogliomas: The Mayo Clinic experience
- (1992) J Neurosurg , vol.76 , pp. 428-434
- Shaw, E.G.¹ Scheithauer, B.W.² O'Fallon, J.R.³

31
- 0030765194
- Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
- (1997) Cancer Chemother Pharmacol , vol.40 , pp. 484-488
- Bower, M.¹ Newlands, E.S.² Bleehen, N.M.³

32
- 0027972896
- Chemotherapy for anaplastic oligodendroglioma: National Cancer Institute of Canada Clinical Trials Group
- (1994) J Clin Oncol , vol.12 , pp. 2013-2021
- Cairncross, G.¹ Macdonald, D.² Ludwin, S.³

33
- 0031963150
- Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors
- (1998) Int J Radiat Oncol Biol Phys , vol.40 , pp. 57-63
- Prados, M.D.¹ Larson, D.A.² Lamborn, K.³

34
- 0027462531
- Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma
- (1993) J Clin Oncol , vol.11 , pp. 77-83
- Schold S.C., Jr.¹ Herndon, J.E.² Burger, P.C.³

35
- 0032877838
- Combined treatment modality for anaplastic oligodendroglioma: A phase II study
- (1999) J Neurooncol , vol.43 , pp. 179-185
- Jeremic, B.¹ Shibamoto, Y.² Gruijicic, D.³

36
- 0033951824
- Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
- (2000) J Clin Oncol , vol.18 , pp. 636-645
- Smith, J.S.¹ Perry, A.² Borell, T.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.